Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026

Impact · against what's priced in

The Nasdaq-100 inclusion for MRNA and removal for WBD create short-term technical catalysts that are distinct from the fundamental valuations of either company. MRNA's price is currently driven by oncology clinical results and cash burn, making index-driven passive inflows a new, non-fundamental tailwind.

MRNA+0.20: Not in the price yet
In context: The current price pays for oncology platform validation and respiratory franchise revenue; it does not account for the forced passive buying associated with joining an index tracked by $800 billion in AUM.
What MRNA's price assumes · Sep 11

Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026

MRNA▲267%
pharmaceuticals
healthcare
WBD
biotechnology
index composition
index rebalance
nasdaq 100

Top 1 mover · tap to explore

Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026

What matters in this story

AARDVARK THERAPEUTICS (NASDAQ: AARD) SECURITIES CLASS ACTION: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Investors to Secure Counsel Before Important October 13 Deadline

Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026

What matters in this story

AARDVARK THERAPEUTICS (NASDAQ: AARD) SECURITIES CLASS ACTION: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Investors to Secure Counsel Before Important October 13 Deadline

How each ticker is affected

Track these names every morning.

Deadline Alert: Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

ROSEN, LEADING INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY

Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026

What matters in this story

Next reads from the same story arc

AARDVARK THERAPEUTICS (NASDAQ: AARD) SECURITIES CLASS ACTION: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Investors to Secure Counsel Before Important October 13 Deadline

Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026

What matters in this story

Next reads from the same story arc

AARDVARK THERAPEUTICS (NASDAQ: AARD) SECURITIES CLASS ACTION: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Investors to Secure Counsel Before Important October 13 Deadline

How each ticker is affected

Track these names every morning.

Deadline Alert: Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

ROSEN, LEADING INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY

Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights